S
Sumner E. Thompson
Researcher at Emory University
Publications - 41
Citations - 4317
Sumner E. Thompson is an academic researcher from Emory University. The author has contributed to research in topics: Neisseria gonorrhoeae & Penicillin. The author has an hindex of 23, co-authored 41 publications receiving 4250 citations. Previous affiliations of Sumner E. Thompson include Centers for Disease Control and Prevention & United States Department of Health and Human Services.
Papers
More filters
Journal ArticleDOI
Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.
TL;DR: Tubal factor infertility after PID was associated with number and severity of PID episodes, and tubal morphology in women from couples for whom evaluation was incomplete indicated that 165 (12.2%) patients and 4 (0.9%) of the control subjects had abnormal tubal function or morphology after index laparoscopy.
Journal ArticleDOI
Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men
Stephen C. Hadler,Donald P. Francis,James E. Maynard,Sumner E. Thompson,Franklyn N. Judson,Dean F. Echenberg,David G. Ostrow,Paul M. O'Malley,Kent A. Penley,Norman L. Altman,Erwin H. Braff,Gregory F. Shipman,Patrick J. Coleman,Eric J. Mandel +13 more
TL;DR: Both antibody loss and the risk of severe disease should be considered when booster-dose strategies for the hepatitis B vaccine are being designed.
Journal ArticleDOI
Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis
Michael S. Saag,William G. Powderly,Gretchen A. Cloud,P Robinson,Michael H. Grieco,P K Sharkey,Sumner E. Thompson,Alan M. Sugar,Carmelita U. Tuazon,J F Fisher +9 more
TL;DR: Fluconazole is an effective alternative to amphotericin B as primary treatment of cryptococcal meningitis in patients with AIDS and single-drug therapy with either drug is most effective in patients who are at low risk for treatment failure.
Journal ArticleDOI
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.
Donald P. Francis,Stephen C. Hadler,Sumner E. Thompson,James E. Maynard,David G. Ostrow,Norman L. Altman,Erwin H. Braff,Paul M. O'Malley,Donald Hawkins,Franklyn N. Judson,Kent A. Penley,Thom Nylund,Graham Christie,Frank Meyers,Joseph N. Moore,Ann Gardner,Irene L. Doto,Joe H. Miller,Gladys H. Reynolds,Bert L. Murphy,Charles A. Schable,Brian T. Clark,James Curran,Allan G. Redeker +23 more
TL;DR: This vaccine appears to be safe, immunogenic, and efficacious in preventing infection with hepatitis B virus.
Journal ArticleDOI
Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.
TL;DR: It is concluded that untreated DMAC significantly shortens survival, and results indicate that patients with DMAC who receive antimycobacterial therapy do not experience the shortened survival seen in untreatedDMAC.